Literature DB >> 16273792

The Disease Activity Score and the EULAR response criteria.

J Fransen1, P L C M van Riel.   

Abstract

In rheumatoid arthritis (RA), inflammatory activity cannot be measured using one single variable. For this reason the Disease Activity Score (DAS). has been developed. The DAS is a clinical index of RA disease activity that combines information from swollen joints, tender joints, the acute phase response and general health. The DAS-based European League Against Rheumatism (EULAR) response criteria were developed to measure individual response in clinical trials. The EULAR response criteria classify individual patients as non-, moderate, or good responders, dependent on the extent of change and the level of disease activity reached.

Entities:  

Mesh:

Year:  2005        PMID: 16273792

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  199 in total

1.  Contribution of Genetic Factors to Lower DHEAS in Patients with Rheumatoid Arthritis.

Authors:  Lucia Vernerova; Martina Mravcova; Lucia Paulikova; Miroslav Vlcek; Andrea Marko; Milada Meskova; Adela Penesova; Jozef Rovensky; Juraj Wendl; Katarina Raslova; Branislav Vohnout; Ivana Jochmanova; Ivica Lazurova; Zdenko Killinger; Guenter Steiner; Josef Smolen; Richard Imrich
Journal:  Cell Mol Neurobiol       Date:  2017-07-15       Impact factor: 5.046

2.  Pulmonary function test: its correlation with pulmonary high-resolution computed tomography in patients with rheumatoid arthritis.

Authors:  Daza Leonel; Cervantes Lucia; Muñiz A; Hernández Martha-Alicia; Murillo Blanca
Journal:  Rheumatol Int       Date:  2011-04-17       Impact factor: 2.631

3.  Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis.

Authors:  Anthony Russell; Ariel Beresniak; Louis Bessette; Boulos Haraoui; Proton Rahman; Carter Thorne; Ross Maclean; Danielle Dupont
Journal:  Clin Rheumatol       Date:  2008-12-17       Impact factor: 2.980

4.  Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis.

Authors:  Kazutaka Masamoto; Bungo Otsuki; Shunsuke Fujibayashi; Koichiro Shima; Hiromu Ito; Moritoshi Furu; Motomu Hashimoto; Masao Tanaka; Stephen Lyman; Hiroyuki Yoshitomi; Shimei Tanida; Tsuneyo Mimori; Shuichi Matsuda
Journal:  Eur Spine J       Date:  2017-11-28       Impact factor: 3.134

5.  The good EULAR response at the first year is strongly predictive of clinical remission in rheumatoid arthritis: results from the TARAC cohort.

Authors:  Budsakorn Darawankul; Sumapa Chaiamnuay; Rattapol Pakchotanon; Paijit Asavatanabodee; Pongthorn Narongroeknawin
Journal:  Clin Rheumatol       Date:  2014-07-26       Impact factor: 2.980

6.  Central corneal thickness and corneal curvature in patients with rheumatoid arthritis.

Authors:  Fatih Özcura; Serdar Aktaş; Yasemin Özkan; Mehmet Tetikoğlu; Hacı Murat Sağdik
Journal:  Int Ophthalmol       Date:  2016-05-09       Impact factor: 2.031

7.  Potential of (18)F-FDG-PET as a valuable adjunct to clinical and response assessment in rheumatoid arthritis and seronegative spondyloarthropathies.

Authors:  Vishu Vijayant; Manjit Sarma; Hrushikesh Aurangabadkar; Lata Bichile; Sandip Basu
Journal:  World J Radiol       Date:  2012-12-28

8.  [Structural and morphological changes in the eyes of arterial hypertensive patients with and without anti-CCP-positive rheumatoid arthritis].

Authors:  M Pahlitzsch; R Zielke; S Schlittgen; K Göbel; R Alten; C Erb
Journal:  Ophthalmologe       Date:  2017-04       Impact factor: 1.059

9.  Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients.

Authors:  M Ghavipour; G Sotoudeh; E Tavakoli; K Mowla; J Hasanzadeh; Z Mazloom
Journal:  Eur J Clin Nutr       Date:  2016-08-31       Impact factor: 4.016

10.  Serum levels of calreticulin in correlation with disease activity in patients with rheumatoid arthritis.

Authors:  Min Ni; Wei Wei; Yichao Wang; Na Zhang; Hongmei Ding; Chen Shen; Fang Zheng
Journal:  J Clin Immunol       Date:  2013-03-27       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.